Bank Of New York Mellon Corp Spero Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $42,996 - $432,293	-58,104 Reduced 79.52%	14,966 $11,000
Q1 2022 May 11, 2022	SELL	$7.87 - $15.15 $15,189 - $29,239	-1,930 Reduced 2.57%	73,070 $636,000
Q4 2021 Feb 11, 2022	BUY	$13.09 - $18.77 $10,380 - $14,884	793 Added 1.07%	75,000 $1.2 Million
Q3 2021 Nov 12, 2021	BUY	$13.03 - $19.51 $99,184 - $148,510	7,612 Added 11.43%	74,207 $1.37 Million
Q2 2021 Aug 11, 2021	BUY	$12.22 - $15.79 $41,829 - $54,049	3,423 Added 5.42%	66,595 $929,000
Q1 2021 May 13, 2021	SELL	$13.23 - $21.48 $88,786 - $144,152	-6,711 Reduced 9.6%	63,172 $929,000
Q4 2020 Feb 09, 2021	BUY	$11.65 - $22.07 $213,859 - $405,138	18,357 Added 35.63%	69,883 $1.36 Million
Q3 2020 Nov 12, 2020	BUY	$8.96 - $14.12 $14,237 - $22,436	1,589 Added 3.18%	51,526 $575,000
Q2 2020 Aug 12, 2020	BUY	$7.27 - $14.18 $28,156 - $54,919	3,873 Added 8.41%	49,937 $675,000
Q1 2020 May 06, 2020	BUY	$5.27 - $10.41 $43,688 - $86,298	8,290 Added 21.95%	46,064 $372,000
Q4 2019 Feb 14, 2020	BUY	$9.46 - $12.16 $5,212 - $6,700	551 Added 1.48%	37,774 $363,000
Q3 2019 Nov 07, 2019	BUY	$9.01 - $12.55 $26,525 - $36,947	2,944 Added 8.59%	37,223 $394,000
Q2 2019 Aug 12, 2019	BUY	$10.25 - $14.36 $7,257 - $10,166	708 Added 2.11%	34,279 $395,000
Q1 2019 May 14, 2019	SELL	$6.26 - $13.31 $19,687 - $41,859	-3,145 Reduced 8.57%	33,571 $430,000
Q4 2018 Feb 11, 2019	BUY	$5.69 - $11.28 $50,572 - $100,256	8,888 Added 31.94%	36,716 $226,000
Q3 2018 Nov 09, 2018	BUY	$9.69 - $17.79 $30,416 - $55,842	3,139 Added 12.71%	27,828 $0
Q2 2018 Aug 06, 2018	BUY	$10.41 - $17.85 $109,200 - $187,246	10,490 Added 73.88%	24,689 $363,000
Q1 2018 May 15, 2018	BUY	$9.96 - $14.61 $141,422 - $207,447	14,199 New	14,199 $202,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$4.43 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$2.08 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.6 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$1.26 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$1.15 Million
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account